NCT01068613 Safety and Efficacy of Multiple Doses of QAX028 in Chronic Obstructive Pulmonary Disease (COPD) Patients Status COMPLETED Phase PHASE2
NCT01068600 Comparison of Efficacy of Indacaterol Versus Placebo Over 12 Weeks Status COMPLETED Phase PHASE3
NCT01068184 A Study to Assess Safety, Tolerability and Pharmacokinetics of of AZD6553 in Healthy Volunteers and Patients With Chronic Obstructive Pulmonary Disease (COPD) Status TERMINATED Phase PHASE1
NCT01068145 Two-Part Study to Evaluate the Dose Response of SCH 527123 on Sputum Neutrophilia Following Ozone Challenge in Healthy Subjects and Chronic Obstructive Pulmonary Disease (COPD) Patients (P05567 AM7) Status TERMINATED Phase PHASE1
NCT01061970 Efficacy and Safety of Fispemifene in the Treatment of Hypogonadal Men With Chronic Obstructive Pulmonary Disease That Are on Oral Glucocorticoid Therapy Status COMPLETED Phase PHASE2
NCT01058213 Nurse Managed Sequential Strength Training and Bicycle Training in Chronic Obstructive Pulmonary Disease (COPD) Status COMPLETED Phase PHASE2
NCT01057797 Nurse Managed Upper Body Strength Training in Chronic Obstructive Pulmonary Disease (COPD) Status COMPLETED Phase PHASE2
NCT01056081 Inspiratory Muscle Training in Chronic Obstructive Pulmonary Disease Status COMPLETED Phase PHASE3
NCT01050465 MedlinePlus Health Prescriptions: Developing a Pragmatic Approach for Clinic Use Status COMPLETED Phase NA
NCT01049360 Efficacy and Safety Study of Two Fixed-dose Combinations of Aclidinium Bromide With Formoterol Fumarate Compared With Aclidinium Bromide, Formoterol Fumarate and Placebo Status COMPLETED Phase PHASE2
NCT01048333 Evaluate Onset of Effect in Patients With Chronic Obstructive Pulmonary Disease (COPD) Treated With Formoterol Turbuhaler® Status COMPLETED Phase PHASE2
NCT01047553 Study to Evaluate the Safety and Efficacy of Formoterol in a Daily Dose of 18 µg (9 µg Twice Daily) in Japanese Chronic Obstructive Pulmonary Disease (COPD) Patients Status COMPLETED Phase PHASE3
NCT01045213 Integrated Care Program for Chronic Obstructive Pulmonary Disease Status COMPLETED Phase PHASE3
NCT01045161 Efficacy, Safety, and Tolerability of Aclidinium Bromide in the Treatment of Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-38) Status COMPLETED Phase PHASE3
NCT01044927 Advanced eHealth for Chronic Obstructive Pulmonary Disease (COPD) in Colorado Status COMPLETED Phase PHASE3
NCT01044459 Long-term Safety, Tolerability and Efficacy of Aclidinium Bromide in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) (LAS-MD-35) Status COMPLETED Phase PHASE3
NCT01042080 Neurally Adjusted Ventilatory Assist and Synchrony in Patients With Chronic Obstructive Pulmonary Disease (COPD) Status COMPLETED Phase NA
NCT01041586 Bronchoscopic Thermal Vapor Ablation (BTVA) for Lung Volume Reduction Status COMPLETED Phase PHASE1